JPRN-UMIN000039682尚未招募未知
Development of novel allo- or tumor-reactive T cell analyzing assay and exploring novel approach to manipulate T cell response - Development of novel allo- or tumor-reactive T cell analyzing assay and exploring novel approach to manipulate T cell response
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 50years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1, The person with regular hospital visit 2, THe person who have a axiuos about thier health. 3, The person with weight less than 40kg. 4, the person who did blood donation within 1 month. 5, The person possibly be pregnant. 6, The person has a history of infectious disease within a week. 7, The person who has a direct interst with the investigators, like teacher and student. 8, The person who is recognized as inappropriate for the candidate by investigators.
研究者
相似试验
招募中
1 期
TCR-T Cell Immunotherapy of Lung Cancer and Other Solid TumorsNonsmall Cell Lung CancerSolid Tumor, AdultNCT03778814Second Affiliated Hospital of Guangzhou Medical University30
尚未招募
不适用
Induction of neo*antigen specific cytotoxic T cells by autologous tumor lysate-loaded specialized cross*presenting dendritic cells in epithelial ovarian cancer patients treated with neoadjuvant chemotherapy, the NEODOC studyhigh grade serous ovarian cancer10038594ovarian cancerepithelial ovarian cancerNL-OMON54480Radboud Universitair Medisch Centrum10
招募中
不适用
Adoptive therapy with TCR gene-engineered T cells to treat patients with MAGE-C2-positive melanoma and head and neck cancer.head and neck squamous cell carcinomamaligne melanomauveal melanoma100300541002765610040900skin cancerNL-OMON52657Erasmus MC, Universitair Medisch Centrum Rotterdam20
招募中
2 期
MAGE-C2 TCR T cell therapy2024-516922-70-00Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)20
终止
2 期
Analyzing Childhood Recall Antigens in Patients With Pancreatic CancerPancreatic CancerNCT03848182Albert Einstein College of Medicine10